lysine has been researched along with Coronary Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Fang, F; Ji, Y; Li, Y; Liu, W; Zhang, W | 1 |
| Cheng, Q; Fan, C; Hai, Y; Hou, H; Li, Y; Liu, F; Ma, Y; Tan, Y; Wu, T; Zhang, L; Zhang, Y | 1 |
| Cardelo, MP; de la Cruz-Ares, S; García-Rios, A; Gutiérrez-Mariscal, FM; Katsiki, N; López-Miranda, J; Malagón, MM; Pérez-Martínez, P; Torres-Peña, JD; Yubero-Serrano, EM | 1 |
| Berge, RK; Bjørnestad, EØ; Dhar, I; Løland, K; Nilsen, DWT; Nordrehaug, JE; Nygaard, E; Nygård, O; Olset, H; Pedersen, EKR; Svardal, A; Svingen, GFT; Tell, GS; Ueland, PM | 1 |
| von Eckardstein, A | 1 |
| Arnold, AM; Benkeser, D; Djousse, L; Ix, JH; Kizer, JR; Mukamal, KJ; Psaty, BM; Siscovick, DS; Tracy, RP; Zieman, SJ | 1 |
| Li, J; Li, ZQ; Pan, W; Wang, LF | 1 |
| Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G | 1 |
| Dworacka, M; Szczawińska, K; Szymańska, M; Wierusz-Wysocka, B; Winiarska, H | 1 |
| Lazarevic, G; Milojkovic, M; Stefanovic, V; Sunder-Plassmann, R; Tasic, I; Tasic, NM | 1 |
| Brown, BG; Maher, VM | 1 |
| Gruener, N; Karmansky, I; Palant, A; Shnaider, H | 1 |
| Grabowski, EF; McDonnell, SL; Rodriguez, M | 2 |
| Koschinsky, ML; Marcovina, SM | 1 |
| Berg, TJ; Birkeland, KI; Hanssen, KF; Kilhovd, BK; Thorsby, P | 1 |
| Hammel, JP; Hoover-Plow, JL; Joven, J; Pujana, MA; Ribas, M; Simó, JM; Sundaram, IM; Vilella, E | 1 |
| Borum, PR; Broquist, HP | 1 |
| Evangelisti, GB; Faggioli, F; Garagnani, A; Lama, G | 1 |
2 review(s) available for lysine and Coronary Disease
| Article | Year |
|---|---|
Lipoprotein (a) and coronary heart disease.
Topics: Adult; Arteriosclerosis; Coronary Disease; Female; Humans; Lipoprotein(a); Lipoproteins, LDL; Lysine; Male; Middle Aged; Thrombosis | 1995 |
Lipoprotein(a): structural implications for pathophysiology.
Topics: Apolipoproteins A; Arteriosclerosis; Chromosome Mapping; Coronary Disease; Humans; Lipoprotein(a); Lysine; Protein Binding; Risk Factors | 1997 |
4 trial(s) available for lysine and Coronary Disease
| Article | Year |
|---|---|
Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
Topics: Biomarkers; Carotid Artery Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet, Healthy; Endothelium, Vascular; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Olive Oil; Pyruvaldehyde; Single-Blind Method; Vasodilation | 2020 |
Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease.
Topics: Aged; Amino Acid Substitution; Arginine; Asian People; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Coronary Disease; Female; Gene Frequency; Genotype; Humans; Hypolipidemic Agents; Lipids; Lysine; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Pravastatin; Treatment Outcome | 2009 |
Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients.
Topics: Arteriosclerosis; C-Peptide; Carbohydrate Metabolism; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Humans; Islets of Langerhans; Lipid Metabolism; Lipoproteins, HDL; Lysine; Male; Middle Aged; Oxidation-Reduction | 2002 |
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.
Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Epitopes; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Risk Factors | 1999 |
13 other study(ies) available for lysine and Coronary Disease
| Article | Year |
|---|---|
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
Topics: Atherosclerosis; Biomarkers; Coronary Disease; Glycation End Products, Advanced; Humans; Lysine; Receptor for Advanced Glycation End Products | 2022 |
Structural and functional dysbiosis of gut microbiota in Tibetan subjects with coronary heart disease.
Topics: Coronary Disease; Humans; Lysine | 2022 |
Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease.
Topics: Aged; Biomarkers; Coronary Disease; Female; Heart Disease Risk Factors; Humans; Lysine; Male; Methylamines; Middle Aged; Myocardial Infarction; Prospective Studies; Riboflavin | 2020 |
Trimethyllysine and trimethylamine-N-oxide - pathogenic factors or surrogate markers of increased cardiovascular disease risk?
Topics: Biomarkers; Cardiovascular Diseases; Coronary Disease; Humans; Lysine; Methylamines; Myocardial Infarction; Oxides; Virulence Factors | 2020 |
Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
Topics: Aged; Albumins; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Coronary Disease; Creatinine; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Immunoassay; Incidence; Lysine; Male; Oxidative Stress; Proportional Hazards Models; Stroke; Treatment Outcome | 2014 |
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors | 2003 |
The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease.
Topics: Alleles; Coronary Disease; Female; Genotype; Glutamine; Humans; Lysine; Male; Metabolic Diseases; Middle Aged; Phosphoric Diester Hydrolases; Polymorphism, Genetic; Pyrophosphatases | 2007 |
Lysine-binding species of lipoprotein(a) in coronary artery disease.
Topics: Adult; Aged; Coronary Disease; Humans; Lipids; Lipoprotein(a); Lysine; Male; Middle Aged; Regression Analysis | 1994 |
Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis.
Topics: Aspirin; Contrast Media; Coronary Disease; Coronary Thrombosis; Diatrizoate; Diatrizoate Meglumine; Drug Combinations; Endothelium, Vascular; Humans; In Vitro Techniques; Iohexol; Ioxaglic Acid; Lysine; Microscopy, Fluorescence; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors | 1993 |
Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
Topics: Adult; Age of Onset; Apolipoproteins A; Binding Sites; Coronary Disease; Humans; Lipoprotein(a); Lysine; Male; Matched-Pair Analysis; Middle Aged; Molecular Weight; Myocardial Infarction; Odds Ratio; Protein Binding; Protein Isoforms | 2001 |
Some aspects of carnitine nutriture.
Topics: Animals; Carnitine; Catalysis; Coronary Disease; Diabetic Ketoacidosis; Fatty Acids; Humans; Lysine; Methionine; Mitochondria; Muscular Diseases; Myocardium; Nutritional Requirements; Tissue Distribution | 1977 |
[Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Coronary Disease; Female; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Lysine; Male; Middle Aged; Platelet Aggregation | 1978 |
Platelet adhesion/aggregation and endothelial cell function in flowing blood: effects of contrast media.
Topics: Adult; Animals; Aspirin; Cattle; Contrast Media; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Humans; Lysine; Platelet Adhesiveness; Platelet Aggregation | 1991 |